vibegron
Selected indexed studies
- Vibegron. (, 2006) [PMID:39836798]
- Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta-analysis. (Low Urin Tract Symptoms, 2023) [PMID:36863312]
- Vibegron. (, 2012) [PMID:37535798]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta-analysis. (2023) pubmed
- Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. (2024) pubmed
- Vibegron. (2006) pubmed
- Vibegron. (2012) pubmed
- Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial. (2024) pubmed
- International Phase III, Randomized, Double-Blind, Placebo and Active Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR. (2020) pubmed
- Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes. (2025) pubmed
- Evaluating vibegron for the treatment of overactive bladder. (2021) pubmed
- PMID:39808002 (2024) pubmed
- Vibegron 50 mg is the optimal algorithm in the pharmacologic management of overactive bladder: outcomes from a systematic review and meta-analysis. (2020) pubmed